Arthur He
Stock Analyst at HC Wainwright & Co.
(n/a)
# 4,842
Out of 4,842 analysts
62
Total ratings
5%
Success rate
-56.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Arthur He
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRME Prime Medicine | Downgrades: Neutral | n/a | $1.26 | - | 8 | May 20, 2025 | |
| VERA Vera Therapeutics | Assumes: Buy | $75 | $19.99 | +275.28% | 1 | May 5, 2025 | |
| ADAG Adagene | Reiterates: Buy | $8 | $1.95 | +310.26% | 10 | Apr 3, 2025 | |
| ADAP Adaptimmune Therapeutics | Maintains: Buy | $3.5 → $3 | $0.27 | +996.49% | 6 | Apr 1, 2025 | |
| BCAB BioAtla | Reiterates: Neutral | n/a | $0.40 | - | 8 | Mar 31, 2025 | |
| LVTX LAVA Therapeutics | Reiterates: Neutral | $1.5 | $1.33 | +13.21% | 10 | Mar 31, 2025 | |
| NKTR Nektar Therapeutics | Reiterates: Buy | $6.5 | $0.73 | +785.92% | 3 | Mar 13, 2025 | |
| SLDB Solid Biosciences | Maintains: Buy | $16 → $20 | $3.30 | +506.98% | 9 | Mar 10, 2025 | |
| HOOK HOOKIPA Pharma | Downgrades: Neutral | n/a | $1.62 | - | 7 | Jan 10, 2025 |
Prime Medicine
May 20, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.26
Upside: -
Vera Therapeutics
May 5, 2025
Assumes: Buy
Price Target: $75
Current: $19.99
Upside: +275.28%
Adagene
Apr 3, 2025
Reiterates: Buy
Price Target: $8
Current: $1.95
Upside: +310.26%
Adaptimmune Therapeutics
Apr 1, 2025
Maintains: Buy
Price Target: $3.5 → $3
Current: $0.27
Upside: +996.49%
BioAtla
Mar 31, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.40
Upside: -
LAVA Therapeutics
Mar 31, 2025
Reiterates: Neutral
Price Target: $1.5
Current: $1.33
Upside: +13.21%
Nektar Therapeutics
Mar 13, 2025
Reiterates: Buy
Price Target: $6.5
Current: $0.73
Upside: +785.92%
Solid Biosciences
Mar 10, 2025
Maintains: Buy
Price Target: $16 → $20
Current: $3.30
Upside: +506.98%
HOOKIPA Pharma
Jan 10, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.62
Upside: -